Inventor · disambiguated record
Anisa Nizarali Virani
Also filed as: VIRANI ANISA NIZARALI
13 granted patents·11 pending applications·166 citations·filing 2011–2025
92Inventor score
Top patents by PatentIndex Score
24 records- 0198US9701674B2Substituted pyrazines as ATR kinase inhibitorsVERTEX PHARMA·Filed 2014·Granted Jul 11, 2017·22 cites·61 claims
- 0298US9365557B2Substituted pyrazin-2-amines as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2014·Granted Jun 14, 2016·27 cites·54 claims
- 0397US8410112B2Compounds useful as inhibitors of ATR kinaseCHARRIER JEAN-DAMIEN·Filed 2011·Granted Apr 2, 2013·56 cites·71 claims
- 0495US11834441B2Substituted tetrahydrofurans as modulators of sodium channelsVERTEX PHARMA·Filed 2020·Granted Dec 5, 2023·4 cites·62 claims
- 0595US11827627B2N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channelsVERTEX PHARMA·Filed 2022·Granted Nov 28, 2023·3 cites·37 claims
- 0694US11919887B2Substituted tetrahydrofurans as modulators of sodium channelsVERTEX PHARMA·Filed 2022·Granted Mar 5, 2024·2 cites·21 claims
- 0794US9334244B2Compounds useful as inhibitors of ATR kinaseCHARRIER JEAN-DAMIEN·Filed 2011·Granted May 10, 2016·12 cites·19 claims
- 0893US12247021B2Substituted tetrahydrofurans as modulators of sodium channelsVERTEX PHARMA·Filed 2023·Granted Mar 11, 2025·1 cites·24 claims
- 0993US8623869B2Compounds useful as inhibitors of ATR kinaseCHARRIER JEAN-DAMIEN·Filed 2011·Granted Jan 7, 2014·20 cites·42 claims
- 1091US10479784B2Substituted pyrazin-2-amines as inhibitors of ATR kinaseVERTEX PHARMA·Filed 2018·Granted Nov 19, 2019·3 cites·10 claims
- 1190US9062008B2Compounds useful as inhibitors of ATR kinaseCHARRIER JEAN-DAMIEN·Filed 2011·Granted Jun 23, 2015·14 cites·2 claims
- 1287US10961232B2Substituted pyrazines as ATR kinase inhibitorsVERTEX PHARMA·Filed 2017·Granted Mar 30, 2021·2 cites·24 claims
- 1385US2025197381A1Substituted tetrahydrofurans as modulators of sodium channelsVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 1480US12258333B2N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channelsVERTEX PHARMA·Filed 2023·Granted Mar 25, 2025·0 cites·22 claims
- 1575US2023030414A1Compounds useful as inhibitors of atr kinaseVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 1669US2025353836A1N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channelsVERTEX PHARMA·Filed 2025·Application pending·0 cites
- 1763US2016311809A1Compounds useful as inhibitors of atr kinaseVERTEX PHARMA·Filed 2016·Application pending·0 cites
- 1863US2014288347A1Compounds useful as inhibitors of atr kinaseVERTEX PHARMA·Filed 2013·Application pending·0 cites
- 1960US2024294512A1Hydroxy and (halo)alkoxy substituted tetrahydrofurans as modulators of sodium channelsVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 2058US2024400544A1N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamide analogs as modulators of sodium channelsVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 2158US2024368135A1Substituted tetrahydrofuran-2-carboxamides as modulators of sodium channelsVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 2257US2025213555A1Substituted tetrahydrofuran analogs as modulators of sodium channelsVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 2354US2016271129A1Compounds useful as inhibitors of atr kinaseVERTEX PHARMA·Filed 2016·Application pending·0 cites
- 2449US2016009723A1Compounds useful as inhibitors of atr kinaseVERTEX PHARMA·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Anisa Nizarali Virani files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →